Cover
Cover | 9 Months Ended |
Sep. 30, 2022 shares | |
Cover [Abstract] | |
Document Type | 10-Q/A |
Amendment Flag | true |
Amendment Description | The purpose of this Amendment No. 1 (this “Amendment) to our Quarterly Report on Form 10-Q for the period ended September 30, 2022 (the “Form 10-Q), as filed with the Securities and Exchange Commission (the “SEC”) on October 11, 2022, is solely to incorporate the hyperlink to the iXBRL data related to Form 10-Q as filed. |
Document Quarterly Report | true |
Document Transition Report | false |
Document Period End Date | Sep. 30, 2022 |
Document Fiscal Period Focus | Q3 |
Document Fiscal Year Focus | 2022 |
Current Fiscal Year End Date | --12-31 |
Entity File Number | 000-55269 |
Entity Registrant Name | EQUATOR Beverage Company |
Entity Central Index Key | 0001414953 |
Entity Tax Identification Number | 26-0884348 |
Entity Incorporation, State or Country Code | DE |
Entity Address, Address Line One | 185 Hudson Street |
Entity Address, Address Line Two | Floor 25 |
Entity Address, City or Town | Jersey City |
Entity Address, State or Province | NJ |
Entity Address, Postal Zip Code | 07302 |
City Area Code | 929 |
Local Phone Number | 264 7944 |
Entity Current Reporting Status | Yes |
Entity Interactive Data Current | Yes |
Entity Filer Category | Non-accelerated Filer |
Entity Small Business | true |
Entity Emerging Growth Company | false |
Entity Shell Company | false |
Entity Common Stock, Shares Outstanding | 15,917,115 |
Condensed Balance Sheets (Unaud
Condensed Balance Sheets (Unaudited) - USD ($) | Sep. 30, 2022 | Dec. 31, 2021 |
CURRENT ASSETS: | ||
Cash and cash equivalents | $ 9,622 | $ 46,481 |
Accounts receivable, net | 256,679 | 108,635 |
Inventory | 250,810 | 234,566 |
Supplier deposits | 29,850 | 28,000 |
Prepaid expenses | 32,266 | 11,702 |
Security deposit | 113 | 113 |
Total Current Assets | 579,340 | 429,497 |
CURRENT LIABILITIES: | ||
Accounts payable and accrued expenses | 113,158 | 58,944 |
Related party loans | 275,000 | |
SBA Loans | ||
Total Current Liabilities | 388,158 | 58,944 |
STOCKHOLDERS’ EQUITY | ||
Common stock, 20,000,000 shares authorized at $0.001 par value, 15,917,115 and 15,548,790 shares issued and outstanding, at September 30, 2022 and December 31, 2021, respectively | 15,917 | 15,549 |
Additional paid-in capital | 23,737,264 | 23,745,449 |
Accumulated deficit | (23,561,999) | (23,390,445) |
Total Stockholders’ Equity | 191,182 | 370,553 |
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $ 579,340 | $ 429,497 |
Condensed Balance Sheets (Una_2
Condensed Balance Sheets (Unaudited) (Parenthetical) - $ / shares | Sep. 30, 2022 | Dec. 31, 2021 |
Statement of Financial Position [Abstract] | ||
Common stock, shares authorized | 20,000,000 | 20,000,000 |
Common stock, par value | $ 0.001 | $ 0.001 |
Common stock, shares issued | 15,917,115 | 15,548,790 |
Common stock, shares outstanding | 15,917,115 | 15,548,790 |
Condensed Statements of Operati
Condensed Statements of Operations (Unaudited) - USD ($) | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | |
Income Statement [Abstract] | ||||
Revenue | $ 548,973 | $ 477,013 | $ 1,469,732 | $ 1,495,058 |
Cost of Revenue | 380,864 | 255,266 | 966,207 | 793,234 |
Gross Profit | 168,109 | 221,747 | 503,525 | 701,824 |
Operating Expenses | ||||
Selling, general and administrative | 198,122 | 223,571 | 667,918 | 645,341 |
(Loss)/Income from Operations | (30,013) | (1,824) | (164,393) | 56,483 |
Other (Expense)/ Income | (3,335) | (7,161) | 35,508 | |
(Loss)/ Income Before Provision for Income Taxes | (33,348) | (1,824) | (171,554) | 91,991 |
Benefit/(Provision) for Income Taxes | ||||
Net (Loss)/Income | $ (33,348) | $ (1,824) | $ (171,554) | $ 91,991 |
Net (Loss)/Income per common share, basic and diluted | $ 0 | $ 0 | $ (0.01) | $ 0.01 |
Weighted average number of common shares outstanding, basic and diluted | 16,092,401 | 16,000,276 | 15,732,060 | 15,593,385 |
Condensed Statements of Cash Fl
Condensed Statements of Cash Flows (Unaudited) - USD ($) | 9 Months Ended | |
Sep. 30, 2022 | Sep. 30, 2021 | |
Cash flows from operating activities: | ||
Net income/(loss) | $ (171,554) | $ 91,991 |
Adjustments to reconcile net loss to net cash used in operating activities: | ||
Stock issued to directors and employees | 159,923 | 147,656 |
SBA Loan Forgiveness | (35,508) | |
Changes in assets and liabilities: | ||
Increase in accounts receivable | (148,044) | (61,351) |
Increase in inventory | (16,244) | (171,902) |
Increase in supplier deposits | (1,850) | 8,000 |
(Increase)/Decrease in prepaid expenses and security deposit | (20,564) | 6,679 |
Increase in accounts payable and accrued expenses | 54,213 | 112,287 |
Increase in accrued payroll to officers | ||
Net cash used in operating activities | (144,120) | 97,852 |
Net cash provided by/ (used in) financing activities: | ||
Proceeds from related party loan | 295,000 | |
Repayments of from related party loan | (20,000) | |
Proceeds from options exercise | 25,448 | |
Shares repurchased for cancellation | (193,187) | (102,316) |
Net cash provided by financing activities | 107,261 | (102,316) |
Net decrease in cash and cash equivalents | (36,859) | (4,464) |
Cash and cash equivalents at beginning of period | 46,481 | 50,233 |
Cash and cash equivalents at end of periods | $ 9,622 | $ 45,769 |
Condensed Statements of Cash _2
Condensed Statements of Cash Flows (Unaudited) (Parenthetical) | 9 Months Ended |
Sep. 30, 2022 USD ($) shares | |
Director And Officer [Member] | |
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items] | |
Stock issued to directors and officers, shares | shares | 1,198,554 |
Stock issued to directors and officers, value | $ | $ 184,408 |
Condensed Statements of Changes
Condensed Statements of Changes in Stockholders' Equity (Unaudited) - USD ($) | Common Stock [Member] | Additional Paid-in Capital [Member] | Accumulated Deficit [Member] | Total |
Balance at Dec. 31, 2020 | $ 15,305 | $ 23,644,945 | $ (23,430,337) | $ 229,913 |
Balance, shares at Dec. 31, 2020 | 15,305,120 | |||
Stock issued to Directors and employees | $ 147 | 50,028 | 50,175 | |
Stock issued to Directors and employees, shares | 147,375 | |||
Net Income (loss) | 12,643 | 12,643 | ||
Balance at Mar. 31, 2021 | $ 15,452 | 23,714,973 | (23,417,694) | 312,731 |
Balance, shares at Mar. 31, 2021 | 15,452,495 | |||
Balance at Dec. 31, 2020 | $ 15,305 | 23,644,945 | (23,430,337) | 229,913 |
Balance, shares at Dec. 31, 2020 | 15,305,120 | |||
Net Income (loss) | 91,991 | |||
Balance at Sep. 30, 2021 | $ 15,403 | 23,694,781 | (23,338,346) | 387,244 |
Balance, shares at Sep. 30, 2021 | 15,769,953 | |||
Balance at Dec. 31, 2020 | $ 15,305 | 23,644,945 | (23,430,337) | 229,913 |
Balance, shares at Dec. 31, 2020 | 15,305,120 | |||
Balance at Dec. 31, 2021 | $ 15,549 | 23,745,449 | (23,390,445) | 370,553 |
Balance, shares at Dec. 31, 2021 | 15,548,903 | |||
Balance at Mar. 31, 2021 | $ 15,452 | 23,714,973 | (23,417,694) | 312,731 |
Balance, shares at Mar. 31, 2021 | 15,452,495 | |||
Stock issued to Directors and employees | $ 187 | 60,108 | 60,295 | |
Stock issued to Directors and employees, shares | 186,958 | |||
Net Income (loss) | 81,172 | 81,172 | ||
Balance at Jun. 30, 2021 | $ 15,639 | 23,775,081 | (23,336,522) | 454,198 |
Balance, shares at Jun. 30, 2021 | 15,639,453 | |||
Stock issued to Directors and employees | $ 131 | 37,105 | 37,235 | |
Stock issued to Directors and employees, shares | 130,500 | |||
Stock repurchased and returned to Treasury | $ (367) | (101,950) | (102,316) | |
Stock repurchased and returned to Treasury, shares | (365,413) | |||
Net Income (loss) | (1,824) | (1,824) | ||
Balance at Sep. 30, 2021 | $ 15,403 | 23,694,781 | (23,338,346) | 387,244 |
Balance, shares at Sep. 30, 2021 | 15,769,953 | |||
Balance at Dec. 31, 2021 | $ 15,549 | 23,745,449 | (23,390,445) | 370,553 |
Balance, shares at Dec. 31, 2021 | 15,548,903 | |||
Stock issued to Directors and employees | $ 682 | 111,323 | 112,005 | |
Stock issued to Directors and employees, shares | 681,750 | |||
Stock repurchased and returned to Treasury | $ (375) | (100,875) | (101,250) | |
Stock repurchased and returned to Treasury, shares | (375,000) | |||
Net Income (loss) | (135,379) | (135,379) | ||
Balance at Mar. 31, 2022 | $ 15,856 | 23,755,897 | (23,525,824) | 245,929 |
Balance, shares at Mar. 31, 2022 | 15,855,653 | |||
Balance at Dec. 31, 2021 | $ 15,549 | 23,745,449 | (23,390,445) | 370,553 |
Balance, shares at Dec. 31, 2021 | 15,548,903 | |||
Net Income (loss) | (171,554) | |||
Balance at Sep. 30, 2022 | $ 15,918 | 23,737,264 | (23,561,999) | 191,182 |
Balance, shares at Sep. 30, 2022 | 15,917,115 | |||
Balance at Mar. 31, 2022 | $ 15,856 | 23,755,897 | (23,525,824) | 245,929 |
Balance, shares at Mar. 31, 2022 | 15,855,653 | |||
Stock issued to Directors and employees | $ 119 | 23,949 | 24,068 | |
Stock issued to Directors and employees, shares | 119,250 | |||
Stock repurchased and returned to Treasury | $ (455) | (91,483) | (91,938) | |
Stock repurchased and returned to Treasury, shares | (455,342) | |||
Net Income (loss) | (2,827) | (2,827) | ||
Exercise of stock options | $ 159 | 25,289 | 25,448 | |
Exercise of stock options, shares | 159,054 | |||
Balance at Jun. 30, 2022 | $ 15,679 | 23,713,652 | (23,528,651) | 200,680 |
Balance, shares at Jun. 30, 2022 | 15,678,615 | |||
Stock issued to Directors and employees | $ 239 | 23,611 | 23,850 | |
Stock issued to Directors and employees, shares | 238,500 | |||
Net Income (loss) | (33,348) | (33,348) | ||
Balance at Sep. 30, 2022 | $ 15,918 | $ 23,737,264 | $ (23,561,999) | $ 191,182 |
Balance, shares at Sep. 30, 2022 | 15,917,115 |
BUSINESS
BUSINESS | 9 Months Ended |
Sep. 30, 2022 | |
Accounting Policies [Abstract] | |
BUSINESS | NOTE 1 – BUSINESS Overview EQUATOR Beverage Company, a Delaware corporation is headquartered in Jersey City, NJ. EQUATOR’s business is new product development, beverage production, distribution, and sales & marketing of its beverages. Our beverages are Non-GMO Project Verified, and USDA Organic. We produce both nonalcoholic and ready to drink alcoholic beverages. Equator also has a line of sparking energy beverages that are focused on the female consumer. Equator beverages are available in North America, the Caribbean and Bermuda. We package our beverages in 100% recyclable, eco-friendly packaging. The packaging has a low impact on the environment. CURRENT OPERATIONS Sales and Distribution The Company’s flagship product is MOJO Coconut Water. In addition to Coconut Water, the Company produces Sparkling Coconut Water, Coconut Water + Pineapple Juice, and Organic Coconut Water. We seek to grow the market share of our products by expanding our hybrid distribution network through the relationships and efforts of our management and third-party partners and broker network, and new products and packaging. The company packages its beverages in 100% recyclable, Eco-Friendly packaging that can be recycled infinite times and is not made from carbon oil-based packaging. The packaging has a very low impact on the environment, and does not contribute to landfills and the pollution of our bodies of water. Production The Company has multiple sources for its production. The Company’s fruit sources are of high quality. The fruit is part of the overall taste and quality of our products. Currently, the Company has multiple production facilities that it could source products from, each of the facilities could supply our forecasted demand. Competition The beverage industry is competitive. Competitors in our market compete for brand recognition, ingredient sourcing, product shelf space, and e-commerce page rankings. Our competitors have similar distribution channels and retailers to deliver and sell their products. Government Regulation Within the United States, beverages are governed by the U.S. Food and Drug Administration (the “FDA”). As such, it is necessary for the Company to establish, maintain and make available for inspection records as well as to develop labels (including nutrition information) that meet FDA requirements. The Company’s production facilities are subject to FDA regulation. Employees As of September 30, 2022, the Company had two employees. The Company also uses the services of contractors, consultants and other third-parties. We contract with food brokers to represent our products to specific specialized sales channels. We utilize the services of direct sales and distribution companies that deliver and sell our products to their customers. We contract with manufacturing facilities to produce our products and outsource the storage and transportation of our products. CORPORATE HISTORY AND DEVELOPMENT The Company was incorporated in 2007 and began producing MOJO branded products in 2016. EQUATOR Beverage Company is headquartered in Jersey City, New Jersey and our internet site is www.EquatorBeverage.com. EQUATOR’s stock is traded on the OTCQB under the symbol MOJO. On June 8, 2022, the Board of Directors and majority stockholder of the Company approved a change of name from MOJO Organics, Inc. to EQUATOR Beverage Company. This change of name was filed with the State of Delaware and became effective July 5, 2022. Interim Financial Statements The accompanying unaudited interim condensed financial statements have been prepared pursuant to the rules and regulations for reporting on Form 10-Q and article 10 of Regulation S-X and the related rules and regulations of the Securities and Exchange Commission (“SEC”). Accordingly, certain information and disclosures required by accounting principles generally accepted in the United States of America (“GAAP”) for complete financial statements have been condensed or omitted pursuant to such rules and regulations. However, the Company believes that the disclosures included in these financial statements are adequate to make the information presented not misleading. The unaudited interim condensed financial statements included in this document have been prepared on the same basis as the annual audited financial statements, and in the Company’s opinion, reflect all adjustments necessary for a fair presentation in accordance with GAAP and SEC regulations for interim financial statements. The results for the three and nine months ended September 30, 2022 are not necessarily indicative of the results that the Company will have for any subsequent period. These unaudited condensed financial statements should be read in conjunction with the audited financial statements and the notes to those statements for the year ended December 31, 2021 included in the Company’s Annual Report on Form 10-K. |
SUMMARY OF SIGNIFICANT ACCOUNTI
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | 9 Months Ended |
Sep. 30, 2022 | |
Accounting Policies [Abstract] | |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Use of Estimates The financial statements are prepared in conformity with accounting principles generally accepted in the United States (“GAAP”). Management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Cash and Cash Equivalents Cash equivalents include investment instruments and time deposits purchased with a maturity of three months or less. As of September 30, 2022, and September 30, 2021, the Company did no Accounts Receivable Accounts receivable are stated at the amount management expects to collect from outstanding balances. The Company provides for probable uncollectible amounts based upon its assessment of the current status of the individual receivables and after using reasonable collection efforts. The allowance for doubtful accounts as of September 30, 2022 and 2021 was zero Inventory Inventory, consisting solely of finished goods, are stated at the lower of cost (first-in, first-out method) or net realizable value (“NRV”). If necessary, the Company provides allowances to adjust the carrying value of its inventories to NRV when NRV is below cost. There were no such adjustments in 2022 or 2021. Revenue Recognition Revenue from sales of products is recognized when the related performance obligation is satisfied. The Company’s performance obligation is satisfied upon the shipment or delivery of products to customers. The Company’s products are sold on cash and credit terms which are established in accordance with standardized industry practices and typically require payment within 30 days of delivery. Costs incurred for sales incentives and discounts are accounted for as reductions in revenue. Deductions from Revenue Costs incurred for sales incentives and discounts are accounted for as reductions in revenue. These costs include payments to customers for performing merchandising activities on our behalf, including in store displays, promotions for new items and obtaining optimum shelf space. Shipping and Handling Costs Shipping and Handling Costs incurred to move finished goods from our distribution center to customer locations are included in the line Selling, General and Administrative Expenses in our Statements of Operations. Net Income/(Loss) Per Common Share The Company computes per share amounts in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 260, “ There are no Income Taxes The Net Operating Loss Carryforwards for federal taxes was $ 3,754,634 3,754,634 788,473 337,917 1,126,390 zero The Company provides for income taxes using the asset and liability approach in accounting for income taxes. Deferred tax assets and liabilities are recorded based on the differences between the financial statement and tax bases of assets and liabilities and the tax rates in effect when these differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance if, based on the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. The Company did no As of September 30, 2022, and September 30, 2021, the Company had no accrued interest or penalties because there were none. The Company had no Federal or State tax examinations in the past nor does it have any at the current time. SCHEDULE OF DEFERRED TAX ASSETS Tax Rate 2022 2021 Deferred Tax Asset as Tax Rate 2022 2021 Federal 21 % $ 788,473 $ 776,124 State of New Jersey 9 % $ 337,917 $ 332,625 Total $ 1,126,390 $ 1,108,749 Fair value of financial instruments The carrying amounts of financial instruments, which include cash, accounts receivable, accounts payable and accrued expense, approximate their fair values due to their short-term nature. |
COMMITMENTS AND CONTINGENCIES
COMMITMENTS AND CONTINGENCIES | 9 Months Ended |
Sep. 30, 2022 | |
Commitments and Contingencies Disclosure [Abstract] | |
COMMITMENTS AND CONTINGENCIES | NOTE 3 – COMMITMENTS AND CONTINGENCIES Employment Agreement Pursuant to the Amended and Restated Employment Agreement (“the Agreement”) dated April 6, 2017 and amended on September 1, 2022, Mr. Simpson is paid a salary of $ 8,000 67,000 Mr. Simpson is also paid an annual bonus comprised of cash and non-trading, restricted Common Stock based on the achievement of performance goals established by the Board of Directors of the Company and set forth in the Agreement. The cash bonus is established at $ 44,400 200,000 Pursuant to the Agreement, if Mr. Simpson’s employment is terminated without cause, the Company is obligated to pay him all amounts due under the contract for the remaining term of the contract immediately. At September 30, 2022, the potential liability to EQUATOR Beverage Company was $ 432,000 3,618,000 |
STOCKHOLDERS_ EQUITY
STOCKHOLDERS’ EQUITY | 9 Months Ended |
Sep. 30, 2022 | |
Equity [Abstract] | |
STOCKHOLDERS’ EQUITY | NOTE 4 – STOCKHOLDERS’ EQUITY On July 5, 2022, the State of Delaware approved the 1-for-2 reverse split 40,000,000 20,000,000 On June 8, 2022, the Board of Directors of the Company approved a prospective amendment to the Fourth Article of the Company’s Articles of Incorporation to decrease the authorized common stock from 40,000,000 0.001 20,000,000 0.001 effect a 1-for-2 reverse split of the Company’s Common Stock. In June 2021, the Company decreased its Authorized Shares from 190,000,000 40,000,000 150,000,000 15,917,115 Restricted Stock Issuances During the nine months ended September 30, 2022, 1,211,054 On June 1, 2022, Mr. Simpson exercised his options to purchase 159,054 0.16 25,449 On February 4, 2022, the board of Directors approved the issuance of 525,000 350,000 87,500 Additionally, Mr. Simpson was issued 402,000 75,000 37,500 Stock Purchased for Cancellation During the nine months ended September 30, 2022 the Company purchased 830,342 194,018 During the year ended December 31, 2021 the Company purchased 382,913 765,826 |
STOCK OPTIONS
STOCK OPTIONS | 9 Months Ended |
Sep. 30, 2022 | |
Equity [Abstract] | |
STOCK OPTIONS | NOTE 5 – STOCK OPTIONS On June 1, 2022, Mr. Simpson exercised options to purchase 159,054 0.16 25,449 On February 4, 2022, the Company adjusted the exercise price of the options granted to Mr. Simpson from $ 0.32 0.16 On September 24, 2021, the Company extended the expiration date of the options granted to Mr. Simpson from April 6, 2022 to April 6, 2024 During the year ended December 31, 2021, Mr. Simpson exercised options to purchase 93,750 0.32 30,000 0 The following table summarizes stock option activity: SCHEDULE OF STOCK OPTIONS ACTIVITY Issued To Expiration Days to Exercise Options Outstanding, December 31, 2021 Glenn Simpson 4/6/2024 827 $ 0.16 159,054 Exercised, September 30, 2022 Glenn Simpson 4/6/2024 $ 0.16 (159,054 ) Outstanding, September 30, 2022 Glenn Simpson 4/6/2024 $ 0.16 - During the nine months ended September 30, 2022 and 2021, compensation expense related to stock options was $ 0 no |
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS | 9 Months Ended |
Sep. 30, 2022 | |
Related Party Transactions [Abstract] | |
RELATED PARTY TRANSACTIONS | NOTE 6 – RELATED PARTY TRANSACTIONS During the nine months ended September 30, 2022, Mr. Simpson lent funds to the Company. As of September 30, 2022, the loan payable to Mr. Simpson was $ 275,000 On June 1, 2022, Mr. Simpson exercised 159,054 0.16 159,054 25,449 During the year ended December 31, 2021, Mr. Simpson exercised 93,750 0.32 93,750 30,000 |
SBA LOANS _CARES ACT_
SBA LOANS “CARES ACT” | 9 Months Ended |
Sep. 30, 2022 | |
Debt Disclosure [Abstract] | |
SBA LOANS “CARES ACT” | NOTE 7 – SBA LOANS “CARES ACT” In January 2021, the Company received the loan forgiveness decision from the SBA for the loan proceeds under the Paycheck Protection Program. The full amount of the loan amounting $ 35,508 |
SUMMARY OF SIGNIFICANT ACCOUN_2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) | 9 Months Ended |
Sep. 30, 2022 | |
Accounting Policies [Abstract] | |
Use of Estimates | Use of Estimates The financial statements are prepared in conformity with accounting principles generally accepted in the United States (“GAAP”). Management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. |
Cash and Cash Equivalents | Cash and Cash Equivalents Cash equivalents include investment instruments and time deposits purchased with a maturity of three months or less. As of September 30, 2022, and September 30, 2021, the Company did no |
Accounts Receivable | Accounts Receivable Accounts receivable are stated at the amount management expects to collect from outstanding balances. The Company provides for probable uncollectible amounts based upon its assessment of the current status of the individual receivables and after using reasonable collection efforts. The allowance for doubtful accounts as of September 30, 2022 and 2021 was zero |
Inventory | Inventory Inventory, consisting solely of finished goods, are stated at the lower of cost (first-in, first-out method) or net realizable value (“NRV”). If necessary, the Company provides allowances to adjust the carrying value of its inventories to NRV when NRV is below cost. There were no such adjustments in 2022 or 2021. |
Revenue Recognition | Revenue Recognition Revenue from sales of products is recognized when the related performance obligation is satisfied. The Company’s performance obligation is satisfied upon the shipment or delivery of products to customers. The Company’s products are sold on cash and credit terms which are established in accordance with standardized industry practices and typically require payment within 30 days of delivery. Costs incurred for sales incentives and discounts are accounted for as reductions in revenue. |
Deductions from Revenue | Deductions from Revenue Costs incurred for sales incentives and discounts are accounted for as reductions in revenue. These costs include payments to customers for performing merchandising activities on our behalf, including in store displays, promotions for new items and obtaining optimum shelf space. |
Shipping and Handling Costs | Shipping and Handling Costs Shipping and Handling Costs incurred to move finished goods from our distribution center to customer locations are included in the line Selling, General and Administrative Expenses in our Statements of Operations. |
Net Income/(Loss) Per Common Share | Net Income/(Loss) Per Common Share The Company computes per share amounts in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 260, “ There are no |
Income Taxes | Income Taxes The Net Operating Loss Carryforwards for federal taxes was $ 3,754,634 3,754,634 788,473 337,917 1,126,390 zero The Company provides for income taxes using the asset and liability approach in accounting for income taxes. Deferred tax assets and liabilities are recorded based on the differences between the financial statement and tax bases of assets and liabilities and the tax rates in effect when these differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance if, based on the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. The Company did no As of September 30, 2022, and September 30, 2021, the Company had no accrued interest or penalties because there were none. The Company had no Federal or State tax examinations in the past nor does it have any at the current time. SCHEDULE OF DEFERRED TAX ASSETS Tax Rate 2022 2021 Deferred Tax Asset as Tax Rate 2022 2021 Federal 21 % $ 788,473 $ 776,124 State of New Jersey 9 % $ 337,917 $ 332,625 Total $ 1,126,390 $ 1,108,749 |
Fair value of financial instruments | Fair value of financial instruments The carrying amounts of financial instruments, which include cash, accounts receivable, accounts payable and accrued expense, approximate their fair values due to their short-term nature. |
SUMMARY OF SIGNIFICANT ACCOUN_3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) | 9 Months Ended |
Sep. 30, 2022 | |
Accounting Policies [Abstract] | |
SCHEDULE OF DEFERRED TAX ASSETS | SCHEDULE OF DEFERRED TAX ASSETS Tax Rate 2022 2021 Deferred Tax Asset as Tax Rate 2022 2021 Federal 21 % $ 788,473 $ 776,124 State of New Jersey 9 % $ 337,917 $ 332,625 Total $ 1,126,390 $ 1,108,749 |
STOCK OPTIONS (Tables)
STOCK OPTIONS (Tables) | 9 Months Ended |
Sep. 30, 2022 | |
Equity [Abstract] | |
SCHEDULE OF STOCK OPTIONS ACTIVITY | The following table summarizes stock option activity: SCHEDULE OF STOCK OPTIONS ACTIVITY Issued To Expiration Days to Exercise Options Outstanding, December 31, 2021 Glenn Simpson 4/6/2024 827 $ 0.16 159,054 Exercised, September 30, 2022 Glenn Simpson 4/6/2024 $ 0.16 (159,054 ) Outstanding, September 30, 2022 Glenn Simpson 4/6/2024 $ 0.16 - |
SCHEDULE OF DEFERRED TAX ASSETS
SCHEDULE OF DEFERRED TAX ASSETS (Details) - USD ($) | 9 Months Ended | |
Sep. 30, 2022 | Sep. 30, 2021 | |
Operating Loss Carryforwards [Line Items] | ||
Total | $ 1,126,390 | $ 1,108,749 |
Domestic Tax Authority [Member] | ||
Operating Loss Carryforwards [Line Items] | ||
Total | $ 788,473 | 776,124 |
Tax rate | 21% | |
State and Local Jurisdiction [Member] | ||
Operating Loss Carryforwards [Line Items] | ||
Total | $ 337,917 | $ 332,625 |
Tax rate | 9% |
SUMMARY OF SIGNIFICANT ACCOUN_4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($) | 9 Months Ended | |
Sep. 30, 2022 | Sep. 30, 2021 | |
Operating Loss Carryforwards [Line Items] | ||
Cash equivalents | $ 0 | $ 0 |
Allowance for doubtful accounts | $ 0 | 0 |
Antidilutive securities excluded computation, shares | 0 | |
Deferred tax assets | $ 1,126,390 | 1,108,749 |
Deferred tax liabilities | 0 | 0 |
Domestic Tax Authority [Member] | ||
Operating Loss Carryforwards [Line Items] | ||
Operating loss carryforwards for federal taxes | 3,754,634 | |
Deferred tax assets | 788,473 | 776,124 |
State and Local Jurisdiction [Member] | ||
Operating Loss Carryforwards [Line Items] | ||
Operating loss carryforwards for federal taxes | 3,754,634 | |
Deferred tax assets | 337,917 | $ 332,625 |
Taxes Payable | $ 0 |
COMMITMENTS AND CONTINGENCIES (
COMMITMENTS AND CONTINGENCIES (Details Narrative) - Employment Agreements [Member] - Glenn Simpson [Member] - USD ($) | 9 Months Ended | |
Sep. 02, 2022 | Sep. 30, 2022 | |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | ||
Monthly salary | $ 8,000 | |
Number of shares of non trading, restricted common stock, shares | 67,000 | |
Employee bonus | $ 44,400 | |
Stock bonus, shares | 200,000 | |
Non Trading Restricted Common Stock [Member] | ||
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | ||
Issuance of restricted and non-trading | $ 432,000 | |
Issuance of restricted and non-trading, shares | 3,618,000 |
STOCKHOLDERS_ EQUITY (Details N
STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($) | 3 Months Ended | 9 Months Ended | 12 Months Ended | |||||||
Jul. 05, 2022 | Jun. 08, 2022 | Jun. 01, 2022 | Feb. 04, 2022 | Jun. 30, 2022 | Mar. 31, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Dec. 31, 2021 | Jun. 30, 2021 | |
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items] | ||||||||||
Reverse stock split | 1-for-2 reverse split | effect a 1-for-2 reverse split of the Company’s Common Stock. | ||||||||
Common stock, shares authorized | 40,000,000 | 20,000,000 | 20,000,000 | |||||||
Common stock par value | $ 0.001 | $ 0.001 | ||||||||
Reduction in common stock shares authorized | 150,000,000 | |||||||||
Common stock, shares outstanding | 15,917,115 | 15,548,790 | ||||||||
Stock options exercised | $ 25,448 | |||||||||
Stock repurchased during period value | $ 91,938 | $ 101,250 | $ 102,316 | |||||||
Restricted Common Stock [Member] | ||||||||||
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items] | ||||||||||
Stock repurchased during period shares | 830,342 | 382,913 | ||||||||
Stock repurchased during period value | $ 194,018 | $ 765,826 | ||||||||
Minimum [Member] | ||||||||||
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items] | ||||||||||
Common stock, shares authorized | 40,000,000 | |||||||||
Maximum [Member] | ||||||||||
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items] | ||||||||||
Common stock, shares authorized | 190,000,000 | |||||||||
Board of Directors [Member] | ||||||||||
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items] | ||||||||||
Common stock, shares authorized | 40,000,000 | |||||||||
Common stock par value | $ 0.001 | |||||||||
Issuance of restricted and non-trading, shares | 525,000 | |||||||||
Board of Directors [Member] | Minimum [Member] | ||||||||||
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items] | ||||||||||
Common stock, shares authorized | 20,000,000 | |||||||||
Common stock par value | $ 0.001 | |||||||||
Director and Officers [Member] | Restricted and Non Trading Shares [Member] | ||||||||||
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items] | ||||||||||
Issuance of restricted and non-trading, shares | 1,211,054 | |||||||||
Glenn Simpson [Member] | Restricted and Non Trading Shares [Member] | ||||||||||
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items] | ||||||||||
Share-based compensation arrangement by share-based payment award, options, exercises in period | 159,054 | 93,750 | ||||||||
Share price | $ 0.16 | |||||||||
Stock options exercised | $ 25,449 | |||||||||
Mr. Simpson [Member] | ||||||||||
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items] | ||||||||||
Issuance of restricted and non-trading, shares | 350,000 | 402,000 | ||||||||
Cudia [Member] | ||||||||||
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items] | ||||||||||
Issuance of restricted and non-trading, shares | 87,500 | 37,500 | ||||||||
Mr.Devlin [Member] | ||||||||||
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items] | ||||||||||
Issuance of restricted and non-trading, shares | 87,500 | 75,000 |
SCHEDULE OF STOCK OPTIONS ACTIV
SCHEDULE OF STOCK OPTIONS ACTIVITY (Details) - Glenn Simpson [Member] - $ / shares | 9 Months Ended | |
Sep. 24, 2021 | Sep. 30, 2022 | |
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items] | ||
Stock Options, Expiration Date | Apr. 06, 2024 | |
Equity Option [Member] | ||
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items] | ||
Stock Options, Expiration Date | Apr. 06, 2024 | |
Stock Option, Outstanding, Days to Expiration | 827 days | |
Stock Options, Outstanding, Exercise Price | $ 0.16 | |
Stock Options, Outstanding Options | 159,054 | |
Stock Options, Exercisable, Exercise Price | $ 0.16 | |
Stock Options, Exercised Options | (159,054) | |
Stock Options, Outstanding, Exercise Price | $ 0.16 | |
Stock Options, Exercisable Options |
STOCK OPTIONS (Details Narrativ
STOCK OPTIONS (Details Narrative) - USD ($) | 3 Months Ended | 9 Months Ended | 12 Months Ended | ||||
Jun. 01, 2022 | Feb. 04, 2022 | Sep. 24, 2021 | Jun. 30, 2022 | Sep. 30, 2022 | Sep. 30, 2021 | Dec. 31, 2021 | |
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items] | |||||||
Stock Issued During Period, Value, Stock Options Exercised | $ 25,448 | ||||||
Share-based compensation expense | $ 0 | $ 0 | |||||
Unrecognized compensation cost | $ 0 | ||||||
Glenn Simpson [Member] | |||||||
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items] | |||||||
Expiration date | Apr. 06, 2024 | ||||||
Glenn Simpson [Member] | Maximum [Member] | |||||||
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items] | |||||||
Exercise price | $ 0.32 | ||||||
Glenn Simpson [Member] | Minimum [Member] | |||||||
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items] | |||||||
Exercise price | $ 0.16 | ||||||
Glenn Simpson [Member] | Restricted and Non Trading Shares [Member] | |||||||
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items] | |||||||
Stock issued during period shares stock options exercised | 159,054 | 93,750 | |||||
Exercise price | $ 0.16 | $ 0.32 | |||||
Stock Issued During Period, Value, Stock Options Exercised | $ 25,449 | ||||||
Accrued payroll | $ 30,000 | ||||||
Accrued salaries | $ 0 |
RELATED PARTY TRANSACTIONS (Det
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($) | 3 Months Ended | 12 Months Ended | ||
Jun. 01, 2022 | Jun. 30, 2022 | Dec. 31, 2021 | Sep. 30, 2022 | |
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items] | ||||
Exercise of stock options | $ 25,448 | |||
Mr. Simpson [Member] | ||||
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items] | ||||
Loan payable | $ 275,000 | |||
Glenn Simpson [Member] | Restricted and Non Trading Shares [Member] | ||||
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items] | ||||
Stock issued during period shares stock options exercised | 159,054 | 93,750 | ||
Exercise price | $ 0.16 | $ 0.32 | ||
Exercise of stock options | $ 25,449 | |||
Accrued payroll | $ 30,000 |
SBA LOANS _CARES ACT_ (Details
SBA LOANS “CARES ACT” (Details Narrative) | 1 Months Ended |
Jan. 31, 2021 USD ($) | |
Paycheck Protection Program [Member] | |
Short-Term Debt [Line Items] | |
Debt forgiveness | $ 35,508 |